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Amyloidogs show amazing levels of interspeciﬁc and intraspeciﬁc diversity and are
comprised of a cocktail of genetically-related, but markedly diverse antimicrobial peptides that are grouped
into a superfamily, termed the dermaseptins, comprising several families: dermaseptins (sensu stricto),
phylloseptins, plasticins, dermatoxins, phylloxins, hyposins, caerins, and aureins. Dermaseptin gene
superfamily evolution is characterized by repeated gene duplications and focal hypermutations of the
mature peptide coding sequence, followed by positive (diversifying) selection. We review here molecular
mechanisms leading to these vast combinatorial peptide libraries, and structural and functional properties of
antimicrobial peptides of the dermaseptin and plasticin families, as well as those of dermaseptin S9, an
amyloidogenic peptide with antimicrobial and chemoattractant activities.
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The dermaseptins are a superfamily of antimicrobial peptides that are
made in the skin of Hylidae and Ranidae frogs. These peptides are
genetically related, with a remarkable identity in signal sequences and
intervening sequences of their preproforms but have markedly diverged
to yield several families of peptides that are structurally and functionally
distinct. Different species of frogs are equipped with different sets of
peptides belonging to different families. The impressive divergence
between and within frog species is such that no single peptide from one
species has been foundwith an identical amino acid sequence in another;
orthologous peptides, as well as paralogous peptides, have different
amino acid sequences in different species, and often display differential
biological activity. The studies on the evolution and diversity of frog skin
antimicrobial peptides may help reveal new peptides targeting speciﬁc
microorganisms against which few therapeutic armaments are available.
In addition, the discovery of new isoforms with novel structural and
biochemical properties may also shed light on the exact roles of various
parameters, such as net charge, percent of helical/β-structure, amphi-
pathy and conformational ﬂexibility, on the ability of antimicrobial
peptides to bind to and disrupt bacterial membranes.
2. The dermaseptin superfamily: structurally and functionally
disparate peptides originating from a single gene family
Amphibian skin is an important source of gene-encoded anti-
microbial peptides, with more than half of the ∼900 eukaryotic
peptides described to date isolated from South American Hylidae or
European, Asian or North American Ranidae [http://www.bbcm.univ.
trieste.it.]. Hylids (treefrogs) are one of the largest families of frogs.
There are about 51 genera that are arranged in three subfamilies: Pe-
lodryadinae, Phyllomedusinae, and Hylinae. The Phyllomedusinae sub-
family comprised 57 species divided into seven genus: Agalychnis,
Cruziohyla, Hylomantis, Pachymedusa, Phasmahyla, Phrynomedusa and
Phyllomedusa (Table 1). More than 80 antimicrobial peptides have
been isolated from only twelve species of the Phyllomedusinae sub-
family, belonging to the genera Agalychnis, Hylomantis, Pachymedusa,
and Phyllomedusa. Multiple alignment analysis clearly showed that
these peptides can be grouped to form 7 different families [1]. To date
these families include1 (1) the dermaseptins (sensu stricto) from
Phyllomedusa sauvagii, P. bicolor, P. hypochondryalis, P. distincta, P.
oreades, P. tarsius, P. trinitatis, Pachymedusa dacnicolor, Agalichnis annae,
A. callidryas, A. litodryas, and Hylomantis lemur (Table 1). These
peptides share a signature pattern consisting of a conserved Trp
residue at position 3 and an AA(A/G)KAAL(G/N)A consensus motif in
the midregion; (2) the phylloseptins from Phyllomedusa bicolor, P.1 The proposed nomenclature is as follows [1]: the name of the ﬁrst peptide (parent
peptide) that has been isolated, or that will be isolated from a Phyllomedusinae frog
species should be used as a headgroup name of each peptide belonging to the
considered family. Orthologous peptides should bear the name of the parent peptide,
followed by the ﬁrst capital letter of the name of the Phyllomedusinae species from
which they have been isolated. Paralogous peptides should bear the name of the
parent peptide, followed by the ﬁrst capital letter of the name of the Phyllomedusinae
species from which they have been isolated, and by numbers. In some cases,
classiﬁcation of antimicrobial peptides using the parent peptide’s name followed by
one capital letter is insufﬁcient as several species of the Phyllomedusinae sub-family
share the same ﬁrst letter. In these cases, the second letter written in its small form
should be added to the ﬁrst letter of the name followed by numbers for the paralogous
peptides.hypochondryalis, P. oreades, and Hylomantis lemur (Table 2); (3) the
plasticins from Phyllomedusa sauvagii, P. bicolor, Pachymedusa dacni-
color, and Agalichnis annae, which are rich in Gly and Leu residues
arranged in regular 5-mer motifs GXXXG (where X is any amino acid
residue) (Table 2); (4) the dermatoxins from Phyllomedusa sauvagii, P.
bicolor, Pachymedusa dacnicolor, and Agalichnis annae (Table 2); (5) the
phylloxins from Phyllomedusa sauvagii and P. bicolor (Table 2); (6) the
hypoxins from Phyllomedusa hypochondryalis (Table 2), and (7) the
orphan peptides from Phyllomedusa sauvagii, Pachymedusa dacnicolor,
and Agalichnis annae,which do not resemble anymembers of the other
peptide families (Table 2). All these peptide families show such a
considerable structural variety that their evolutionary relationships
would never have been apparent without the strong conservation of
their biosynthetic precursor preproregions. This conserved prepror-
egion is the hallmark of the dermaseptin superfamily (see Section 3).
Australian frogs belonging to the Pelodryadinae subfamily of the
family Hylidae also produce in their skin numerous antimicrobial
peptides (caerins, aureins, maculatins..) that have no structural
similarity with South American hylid peptides, but the signal peptide
and acidic propiece of the precursors of the aureins and caerins are
highly similar to the corresponding regions of the precursors of the
South American hylid antimicrobial peptides (Table 3). Similarly,
numerous disulﬁde-containing antimicrobial peptides from Eurasian
and North American ranid frogs that belong to the brevinins,
esculentins, nigrocins, palustrins, ranacyclin, ranalexin, ranatuerins,
and temporin families have precursors whose preproregions strikingly
resemble those of preprodermaseptins [2]. Frog skin secretions are also
a rich source of biologically active neuropeptides and hormones that are
very similar to mammalian peptides that are produced in the brain and
the gastrointestinal tract. Most interesting, preprodermaseptins-encod-
ing peptides also include the D-amino acid containing opioid peptides,
dermorphins and deltorphins from P. sauvagei and P. bicolor, respec-
tively, the bradykinin-related peptide [Thr6]-phyllokinin from P.
sauvagei, as well as tryptophyllin-1, a myoactive peptide from Pachy-
medusa dacnicolor relaxing mammalian arterial smooth muscles and
contracting small intestinal smooth muscles [3–9]. The discovery of the
considerable extent of sequence identity between the neuropeptide and
antimicrobial peptide precursors is unprecedented. Thus, although the
two groups of peptides are genetically related and belong to the same
gene superfamily, they have strongly diverged to yield families of
peptides that are both structurally and functionally distinct.
3. The dermaseptin superfamily: gene duplication, focal
hypermutation, and diversifying selection generated a gene-based
combinatorial peptide library
3.1. The one gene-one sequence paradigm
Peptides of the dermaseptin superfamily are synthesized in the
multi-nucleated cells of the granular glands of the skin as prepropep-
tides that are processed by the removal of the signal peptide to the
proform and then stored in the large granules of the glands. Glands
may release their content onto the skin surface by a holocrine
mechanism involving rupture of the plasma membrane and extrusion
of the granules through a duct opening to the surface. Each precursor
results from transcription of a single genetic locus that encodes a
single mature peptide. This one gene-one sequence paradigm
contrasts with the strategy that is employed by vertebrates to produce
families of neuropeptides [10]. The canonical precursor architecture
Table 1
The Dermaseptin family
Amino acid sequences of dermaseptins from South American hylid frogs. Gaps (−) have been introduced to maximize sequence similarities. Identical amino acids have shaded
backgrounds. Carboxamidated amino acids are in italics. New names are proposed according to the frog species names set out in Amphibian species of the world (http://research.
amnh.org/herpetology/amphibia/index.php) and [1]. Phyllomedusinae species: A, annae; B, bicolor; C, callidryas; DA, dacnicolor; DI, distincta; H, hypochondrialis; L, lemur; LI,
litodryas; O, oreades; S, sauvagii; TA, tarsius; TR, trinitatis. Assignment numbers for paralogous peptides are fonction of their publications dates. DRS, DS = dermaseptin; DRP =
dermaseptin-related peptide; DD = dermadistinctin; DRG = dermaseptin-gene related; IRP, isulin-releasing-peptide [6,11,12,20–22,29,32,52,67,81–91].
1539P. Nicolas, C. El Amri / Biochimica et Biophysica Acta 1788 (2009) 1537–1550comprises a N-terminal preprosequence of ∼50 residues that is
remarkably conserved both within and between species (Table 3),
while the C-terminal sequence corresponding to the mature peptides
varies markedly [5–7]. The conserved region comprises a 22-residue
signal peptide followed by an acidic intervening sequence that ends in
a typical prohormone processing signal Lys-Arg that precedes the
single downstream copy of the mature peptide. This conservation also
extends into the 5′- and 3′-untranslated regions of the corresponding
mRNAs. Preprodermaseptin mRNAs thus show a unique pattern of
very high sequence conservation surrounding a region of very high
sequence variability. The contrast between the strikingly conserved
preproregion and the hyperdivergent mature peptides is one of the
most extreme examples observed to date for homologous gene
products within a single order of organisms. Moreover, the pattern
of conserved and variable regions in skin antimicrobial peptideprecursors is the opposite of that of conventional secreted peptides,
suggesting that the conserved preproregion is important for the
biology of the expressing cell.
Genes encoding Dermaseptin B2 and phylloxin appear to be
highly-conserved in terms of structural organization with a small
intron of 137- and 175-bp, respectively, located between exon 1
(encoding signal peptide and ﬁrst three residues of the acidic
intervening sequence) and exon 2 (remainder of acidic intervening
sequence and mature peptide coding sequence through into 3′-non-
translated region) [11–13]. The structural organization and intron/
exon boundary are preserved in the gene that encodes gaegurin 4
(new nomenclature: brevinin-2EMd) from Rana rugosa (Glandirana
emeljanovi) but with an intronic sequence of 3.5-kb [14]. Thus, the
gene duplication events most likely involved complete genetic loci
including intron and exons.
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The remarkable similarity of preproregions of precursors that give
rise to very different peptides in distantly related frogs indicates that
the corresponding genes form a multigene family originating from a
common ancestor. The vast number of different peptides encoded by
this gene family reﬂects an unprecedented degree of gene diversiﬁca-
tion similar to that of the gene families that mediate interactions
between organisms, such as immunoglobulins or venom-derived
toxins [15]. Phylogenetic reconstructions indicated that the genes
encoding peptides of the dermaseptin superfamily in Hylidae and
Ranidae arose from a common ancestral locus, which subsequently
diversiﬁed by several rounds of duplication and subsequent diver-
gence of loci [6,7,16,17]. Most of the duplication events predated the
radiations of ranins and of South American hylids and occurred beforeTable 2
The phylloseptin, plasticin, dermatoxin, phylloxin and hyposin families, and orphan peptide
Phyllomedusinae species: A, annae; B, bicolor; C, callidryas; DA, dacnicolor; H, hypochondria
fonction of their publications dates. PLS, = phylloseptin; DRP = dermaseptin-related pept
Cysteins participating to a disulﬁde bridge are in italics.
⁎Nomenclature for the orphan peptides awaits discovery of novel members [6,51,52,67,84,8cladogenesis in a species ancestral to all these species and arose before
the isolation of India and South America from Africa in a pan-
Gondwanan common ancestor of these species 200–150 mya. There-
fore, the diversity of modern antimicrobial peptide, neuropeptide, and
hormone loci present in hylids and ranids reﬂects the divergence of
these genes since the Mesozoic. Gene duplication was followed by
focal hypermutation of the mature-peptide sequences. The abnor-
mally high bias for transversional versus transitional mutations in the
mature-peptide region of transcripts is the diagnostic ﬁngerprint that
provided evidence for targeted hypermutation of the mature peptide
exon. The transversion/transition (Tv/Ts) ratio of 2 observed for the
mature-peptide region of dermaseptin transcripts is similar to the in
vitro transversion bias measured for the SOS-inducible polymerase V,
and the low processivity of this polymerase [6,7]. These results may
suggest that a targeted mutagenic process involving a DNA Pol V-likes
lis; L, lemur; O, oreades; S, sauvagii. Assignment numbers for paralogous peptides are
ide; DRT, dermatoxin; PBN, Phyllomedusa bicolor new; PLX = phylloxin; HPS, hyposin.
6,90,92–97].
Table 3
Canonical precursor arcitecture of peptides from the dermaseptin superfamily
A/ Diagram of preprodermaseptin cDNAs. The coding region, including the signal peptide, the acidic propiece and the antimicrobial progenitor sequence is drawn as a rectangle.
The signal peptide includes the ﬁrst 22 amino acid residues, while the acidic propiece comprises 21–24 residues. B/ Examples of amino acid sequences of preprodermaseptins
encoding antimicrobial peptides from South American hylid frogs. Identical amino acids have shaded backgrounds. Amino acids in italics are removed during processing of
proforms to expose the extra Gly residue (lower case), which serves as an amide donor for the C-terminal residue of mature peptides. Peptides are named according to the new
proposed nomenclature [1].
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progenitor sequence of antimicrobial peptide loci, but not in the
signal peptide and acidic propiece domains. Skin peptides do not
participate in the general metabolism and physiology of the frog
producing them. Since no deleterious effects are expected when a new
peptide variant rapidly emerges by multiple changes in a current
sequence, the new sequence may bypass the actions of neutral and
negative (purifying) selections. There is strong evidence for diversify-
ing selection (adaptative evolution, positive Darwinian selection)
following dermaseptin gene duplication and focal hypermutation
[6,7,16,18]. Comparisons of the proportions of nonsynonymous
substitutions per nonsynonymous site (Dn) and proportions of
synonymous substitutions per synonymous site (Ds)measured within
the mature-peptide domain among all intraclade comparisons
showed that Dn/Ds is commonly greater than 1 when Ds is less
than 0.5, but less than 1 when Ds is greater than 0.5. Despite the
extreme divergence of the sequences that impaired estimates of Dn
and Ds due to the saturation of nucleotide substitutions, these results
suggest that hylid and ranid loci have been subject to diversifying
selection potentially within the mature-peptide domain. Thus, thecombination of targeted hypermutation to generate great variation
plus the subsequent action of positive selection may explain both the
hypervariation and large number of peptides per species.
The evolutionary pressure which results in the conservation of the
signal peptide and, albeit to a lesser extent, the acidic propiece in
preprodermaseptins is especially striking in view of the extreme
variations in the contiguous antimicrobial peptide domain and the
very ancient history of the gene family. This suggests that these
conserved elements have important functions. Conticello et al. have
suggested that conserved elements in an otherwise hypermutable
DNA sequence might be protected from mutagenesis by speciﬁcally
boundmacromolecules that serve to prime DNA Pol V-like polymerase
in the vicinity [19]. By stopping normal DNA replication, DNA-bound
macromolecules may then create single-strand gaps in the replicating
strand, thus recruiting mutagenic polymerase as part of the damage
response to the lesion. This scenario is attractive in that it provides a
plausible explanation for the conservation of the signal peptide
sequences for millions of years although it lies in the precursors of
very different peptides produced by very distantly related species of
frog.
Table 4
Antimicrobial activity of dermaseptins B against a selected panel of microorganisms1
Microorganisms DRS B1 DRS B2 DRS B3
Mollicutes
Spiroplasma apis 0.3 (1.8) 0.3 (12.5) 3.1 (12.5)
Spiroplasma citri 0.4 (3.1) 0.4 (3.1) 3.1 (12.5)
Spiroplasma ﬂoricola 25 (100) 12.5 (R) 6.2 (50)
Spiroplasma melliferum 1.5 (6.25) 1.5 (6.25) 6.2 (25)
Acholeplasma laidlawii 3.1 (6.25) 3.1 (6.25) 3.1 (6.25)
Mycoplasma galliepticum Ra R 25 (100)
Mycoplasma mycoides R R R
Gracilicutes
Escherichia coli K12 1.5 (1.5) 1.5 (1.5) 1.5 (1.5)
Pseudomonas aeruginosa 6.2 (12.5) 12.5 (12.5) 3.1 (6.2)
Salmonella typhimurium 3.1 (3.1) 3.1 (3.1) 3.1 (3.1)
Rhizobium meliloti 0.3 (3.1) 0.3 (3.1) 0.8 (0.8)
Pasteurella multocida 25 (100) 12.5 (50) 25 (50)
Firmicutes
Staphylococcus aureus 12.5 (25) 12.5 (25) 3.1 (3.1)
Enterobacter faecalis 50 (50) 50 (50) 12.5 (50)
Bacillus megaterium 0.3 (0.3) 0.3 (0.3) 0.8 (0.8)
Corynebacterium glutamicus 1.5 (1.5) 1.5 (1.5) 1.5 (1.5)
Yeasts
Saccharomyces cerevisiae 5.5 (15) 5.5 (15)
Candida albicans 10 (25) 5 (15)
Cryptococcus neoformans 0.3 (15) 1.5 (1.5)
Fungi
Microsporum canis 0.8 1.5
Tricophyton mentagrophytes 10 (25) 15 (30)
Arthroderma simii 3.1 (3.1) 5 (15)
Aspergillus fumigatus 3.1 (6.2) 3.1 (6.2)
Protozoa
Leishmania mexicana 3.1 (3.1) 3.1 (3.1)
Leishmania major 5.5 (15) 1.5 (10)
Hemolysisb
Human erythrocytes N250 N250 N100
1 The antimicrobial activity is expressed as MIC (μM), the minimal peptide
concentration required for total inhibition of cell growth in liquid medium, and (LD),
the peptide concentration required to kill the microorganisms.
a Strains were considered resistant (R) when their growth was not inhibited by
peptide concentrations up to 100 μM.
b dose producing 100% hemolysis after 1 h incubation with the peptide.
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The outcome of massive gene duplication and focal hypermutation
events is a collection of combinatorial peptide libraries, from which
the subsequent positive selection may have retained either the most
relevant peptides targeting speciﬁc microorganisms or a complex
cocktail that enables frogs to survive in microbe-laden environments.
Each ranin or hylid frog species produces its own set of antimicrobial
peptides. Some of these peptides differ by only a few amino acid
substitutions or deletions and have similar biochemical character-
istics, i.e. dermaseptins B1 and B2. Other peptides have widely
different sequences and physicochemical properties, i.e. dermaseptins
and plasticins. The presence in frog skin of numerous antimicrobial
peptides, acting separately or in concert, may have a selective survival
value in habitats laden with microorganisms. Without direct func-
tional characterization, it would have been difﬁcult to predict the
different spectra of these peptides. Moreover, these peptides act in
synergy, with the mixture having up to a 10- to 100-fold greater
antibiotic activity than the peptides separately [6,20]. Hence, the
hypervariability of skin antimicrobial peptides and the proposed
mechanisms of diversiﬁcation could be part of a strategy for providing
frogs with a maximum protection against a wide range of infectious
microorganisms. Also, these antimicrobial peptides with such diversestructures and spectrum of action can be viewed as the successful
evolution of a multi-drug defense system, which minimizes the
chance of microorganisms developing resistance to individual pep-
tides (see Section 7).
South American and Australian hylids, as well as Indian, European,
Asian and North American ranins, have different patterns of distribu-
tion with respect to geography, climate, vegetation and habitats
(aquatic, semi-aquatic, terrestrial, arboreal, torrential, fosserial,
rocky), some of them showing very unusual and extreme adaptations.
Targeted hypermutation of the C-terminal antimicrobial-coding
region of preprodermaseptin genes might have evolved as a way of
increasing genetic diversity and so accelerating the adaptation of frogs
to noxious microbial fauna when microbial predators changed very
rapidly with shifts to new ecological niches.
4. Dermaseptins (sensu stricto): canonical α-helical amphipathic
peptides with broad-spectrum antimicrobial activity and additional
biological functions
Peptides of the dermaseptin family are prototypical members of a
large class of membrane-damaging cationic peptides that undergo
coil-to-helix transition upon binding to lipid bilayers. The ﬁrst
member of the dermaseptin family, named dermaseptin S1, was
isolated from an extract of dried pieces of skin of Phyllomedusa
sauvagei in the early 1990s [21]. This 34-residue peptide has lytic
activity against Gram-positive and Gram-negative bacteria, yeast, and
protozoa, without harmful effects against mammalian cells. It was the
ﬁrst gene-encoded eukaryotic peptide to show lethal effect against
ﬁlamentous fungi that are responsible for opportunistic infections
that result from the immunodeﬁciency syndrome or the use of
immunosuppressive agents. This was followed by the isolation of
adenoregulin (also named dermaseptin B2) from P. bicolor skin, a
peptide that interacts with the adenosine receptor [22], and
dermaseptin B1 [23]. These 2 peptides were thought to be unrelated
until attempts to clone their precursor polypeptides revealed the
presence of a common preproregion and 5′- and 3′-UTRs [24]. Since
then, additional members of the dermaseptin family were rapidly
identiﬁed in various South American species.
Most of the peptides of the dermaseptin family have a very broad
range of antimicrobial activity. The dermaseptins (sensu stricto) are
cidal against a wide spectrum of microorganisms, including molli-
cutes, bacteria, fungi, protozoa, yeast and enveloped viruses. Despite
high sequence similarities, the dermaseptins differ in their potency for
killing the various agents (Table 4). It is noteworthy that the
antimicrobial potencies are essentially independent of the bacterial
envelope structure. The dermaseptins S exhibit synergy of action upon
combination, resulting in some cases in a 100-fold increase in
antibiotic activity of the mixture over the activity of the peptides
separately [20]. Shortening the peptide chain of dermaseptin S3 to
dermaseptin S3-[1–16]-NH2 does not affect the potency of the
peptide. Further reduction of the chain length yield derivatives
gradually showing reduced activity. However, analogues as short as
10–12 residues in length remain fully active against several bacterial
strains [25]. Dermaseptins S derivatives with improved toxicity
proﬁles: a 28-residues [K4, K20]-dermaseptin S4 and 2 shorter versions
[K4]-dermaseptin S4-[1–16] and [K4, K20]-dermaseptin S4-[1–13] have
been investigated for antibacterial activity in vivo, using a peritonitis
model of mice infected with Pseudomonas aeruginosa [26]. Naïve mice
exhibited 75% mortality, compared with 18% and 36% mortality in
mice that received a single i.p. injection (4.5 mg/kg) of [K4]-
dermaseptin S4-[1–16] and [K4, K20]-dermaseptin S4-[1–13], respec-
tively. Dermaseptins S1–S5 exhibit cidal activity against Leishmania
mexicana in its promastigote form at μM doses [27] (Fig. 1).
Immunocytochemical, freeze fracture, and label fracture microscopic
observations show that the peptide generates major perturbations of
the lipid bilayer, leading to death of the parasites. Dermaseptin S3 and
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brane of the intracellular parasite Plasmodium falciparum without
harming that of the mammalian host cell [28]. The resulting
antimalarial activity is allegedly exerted after the harmless peptide
binding to the membrane of the host cell, followed by peptide
translocation across a number of intracellular membrane systems and
interaction with that of the intraerythrocitic parasite. Dermaseptins
DDL and DDK (DI2 and DI1 in the new proposed nomenclature) and
O1 show antiprotozoan activity against Trypanosoma cruzi in its
tryptomastigote and epimastigote forms cultivated in both cell culture
and blood media, without toxicity against mouse erythrocytes and
white blood cells [29]. Dermaseptins S1–S5 display antiviral activity
against herpes simplex virus type I and HIV-1 virus at μM doses [30].
The most potent peptide, dermaseptin S4, inhibits cell-free and cell-
associated HIV-1 infection of D4-CCR5 indicator cells and human
primary T lymphocytes. The peptide is effective against R5 and X4
primary isolates and laboratory-adapted strains of HIV-1. Its activity is
directed against HIV-1 particles by disrupting the virion integrity.
Most of the peptides belonging to the dermaseptin superfamily
have been identiﬁed primarily by their antimicrobial activity. How-
ever, additional biological functions have been recognized thatmay, or
may not be directly associated with pathogen clearance. For instance,
adenoregulin (dermaseptin B2) was ﬁrst isolated by Daly et al. as a
peptide able to stimulate binding of agonists to A1 adenosine
receptors [22], and was further shown to enhance the binding of
agonists to several G-protein coupled receptors in rat brain mem-
branes through a mechanism involving enhancement of guanyl
nucleotide exchange at G-proteins, resulting in a conversion of
receptors into a high afﬁnity state complexed with guanyl nucleo-
tide-free G-protein [31]. On the other hand, dermaseptin B4
signiﬁcantly stimulates insulin release by 1.5 to 2.5-fold in acute
incubations with glucose-responsive BRIN-BD 11 cells [32]. Derma-
septin S1 stimulates microbicidal activities of polymorphonuclear
leukocytes [33]. Treatment of polymorphonuclear leukocytes with
dermaseptin S1 (10–100 nM) stimulates production of reactive
oxygen species and release of myeloperoxidase. In addition, low
peptide concentrations (1–10 nM) prime the stimulation of respira-
tory burst induced by zymosan particles. The induced-burst is
inhibited by selective protein kinase inhibitors, and is associated
with early signaling events such as a rapid and transient elevation ofFig. 1. Electron microscopic observations of Leishmania mexicana promastigotes (A) before
presence of Drs-S1, the ﬂagellated parasites lost their motility. After treatment, the plasma m
structure that still maintains the shape and integrity of the promastigote ghost. Drs-S1 inhicytosolic-free calcium concentration and phospholipase D activity.
These data provide evidence of stimulating and priming properties of
dermaseptin S1 on microbicidal activities of neutrophils, suggesting a
potential role in modulating host-defense mechanisms.
The structure–activity relationships and mechanisms of antimi-
crobial action of dermaseptins have been extensively studied (see A.
Mor, this issue, for an authoritative review). We will only review
brieﬂy some particular points. The mode of antimicrobial action of
most dermaseptins is believed to be the permeation/disruption of the
lipid plasma membrane of the target cells through a “carpet”
mechanism [34,35]. Fluorescence-based studies using liposomes and
surface plasmon resonance analysis of the interaction of dermaseptins
with immobilized bilayers demonstrated that the peptides preferen-
tially bind to negatively charged membranes with association afﬁnity
constants in the range of 107 M−1. CD, FTIR spectroscopy, and 2-D
NMR have shown that dermaseptins S, B, and O form an amphipathic
α-helix in the presence of apolar solvents, or in the presence of SDS
micelles or phospholipids vesicles (Fig. 2) [36–38]. Drs-B2 forms a
well-deﬁned amphipathic helix in SDS spanning residues 11–33 (Fig.
2). There is also a loose helical segment encompassing residues 3–8
that is separated from the well-deﬁned helix by a small hinge region
consisting of residues Val9 and Gly10. Helix 11–33 is totally amphi-
pathic, that is, the apolar side chains (mostly Ala) are aligned on a
portion of the helical cylinder, whereas the polar and charged residues
(Lys) occupy the remaining surface. The position of Drs-B2 relative to
the SDS micelle surface was investigated using paramagnetic probes.
Titration with Mn2+ indicates that segments 8–12 and 24–33 are
accessible to the paramagnetic ion. 5-doxyl spin-labeling experiments
and ﬂuorescence data show that residue Trp3 in the N-terminal
segment of the peptide lies inside the SDS micelles but remains close
to the surface. Thus, these results suggest that Drs-B2 is mainly located
at the interface between SDS micelles and water and that conforma-
tional ﬂexibility of the N-terminal segment and the Val9-Gly10 hinge
region may facilitate the penetration of Trp3 into the SDSmicelles. The
conformational versatility of the N-terminal segment led us to
investigate its role in antimicrobial activity. The N-terminal truncated
analogue Drs-B2-[10–33] is completely devoid of activity. Deleting the
C-terminal peptide helix to give Drs-B2-[1–23] and Drs B2-[1–11]
drastically decreased the antibacterial potency. This demonstrates
that the N-terminal segment is necessary for antibacterial activity ofand (B) after treatment by 5 μM dermaseptin S1. Within 5 min of incubation in the
embrane is peeled off (inset), and the microtubular network is the unique cell surface
bited promastigote growth by 50% at a concentration of 3 μM and by 100% at 10 μM.
Fig. 2. (A) Dermaseptin B2 exhibits alternating hydrophobic and polar/charged
residues along the primary structure and forms α-helical amphipathic helix in a
membrane environment, with polar and apolar amino acids on opposing surfaces along
the long axis of the helix. (B) NMR structures of dermaseptin B2 in 80 mM SDS. Family
of 20 structures obtained from NMR data collected for 0.4 mM Drs-B2 in 80 mM SDS.
Structures were superimposed by ﬁtting the backbone atoms N, C, and C′ from residue
11 to residue 31. Drs-B2 forms a well-deﬁned amphipathic helix in SDS spanning
residues 11–33. There is also a loose helical segment encompassing residues 3–8 that is
separated from the well-deﬁned helix by a small hinge region consisting of residues
Val9 and Gly10. Helix 11–33 is totally amphipathic. (C) Family of 20 structures obtained
from the NMR data determined in 20% TFE with 2 mM Drs-B2. Structures were
superimposed by ﬁtting the backbone atoms N, C, and C′ from residue 3 to residue 18.
Fig. 3. (A) Helical wheel projections showing the distribution of hydrophilic and
hydrophobic amino acids, and electrostatic diagrams of plasticins. Hydrophobic (gray
background), positively charged (pink background), and negatively charged (red
background) side chains are highlighted. The blue and red meshes represent the 1 kT/e
positive and 1 kT/e negative electrostatic ﬁelds of the peptides calculated from the
ﬁnite difference solution of the Poisson–Boltzmann equation. (B) Amino acid sequences,
amphipathic properties and three-dimensional solution structure of dermaseptin S9 in
30% TFE. Dermaseptin S9 has a tripartite structure comprising a highly hydrophobic core
sequence (mean hydrophobicity +4.40 determined by the Liu–Deber scale) ﬂanked by
hydrophilic and charged residues termini (mean hydrophobicity−1.90). Dermaseptin S9
forms α-helix in a membrane environment, but polar and apolar residues are not
segregated on opposing surfaces along the long axis of the helix. The hydrophobic core is
nonamphipathic because it has no hydrophilic residues.
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permeabilization potency.
Comparison of the structures of Drs-B2 in 20% TFE and in 80 mM
SDS also shows that the peptide conformations in these media differ
signiﬁcantly [37] (Fig. 2). The helical structure of Drs-B2 extends from
Trp3 to Ala18 and is followed by a more ﬂexible, loosely deﬁned helix
segment in TFE/water. This suggests that a negatively charged
hydrocarbon–water interface is not essential for α-helix formation,
but it is important for proper conformational adjustment to enable the
peptide helix to interact optimally with the micelle surface. The
electrostatic interactions between the positively charged lysine
residues at the C-terminal domain of the peptide and the anionic
SDS headgroups could drive primary binding and anchoring to the
micelle surface.
According to the carpet-model, cationic peptides initially bind onto
the negatively charged surface of the target membrane and cover it ina carpet-like manner. The high content of anionic lipids in prokaryotic
membranes and their absence from the neutral matrix of erythrocytes
account for the preferential binding of cationic peptides to the outer
leaﬂet of bacterial bilayers through non-speciﬁc long-range electro-
static interactions. The four steps proposed to be involved in the
model are: (i) binding of the cationic peptide to the phospholipid
head groups, with subsequent formation of an amphipathic peptide
helix; (ii) alignment of the helical peptides on the surface of the
membrane so that their hydrophilic surface is facing the phospholipid
head groups; (iii) rotation of the helical peptides leading to
reorientation of the hydrophobic residues toward the hydrophobic
core of the membrane. The resulting spatial segregation of polar and
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permits insertion of a well-deﬁned hydrophobic sector into the lipid
bilayer. Note that the peptides do not become inserted deeply into the
acyl core of the membrane because of the snorkeling of the regularly
spaced lysine side chains that grip it to the membrane surface; and
(iv) disintegration of the peptide-coated membrane by disrupting the
bilayer curvature. As peptides cover the cell surface, transient holes
may be formed. Theymay enable the passage of lowmolecular weight
molecules prior to membrane lysis.
5. Plasticins: membrane-damaging peptides with “chameleon-
like” structural and functional properties
The plasticins are a family of antimicrobial, orthologous peptides of
the dermaseptin superfamily that have very similar amino acid
sequences, hydrophobicities, and amphipathicities but differ mark-
edly in their conformational plasticity and spectrum of activity [6].
This family includes the neutral plasticin-A1 (from Agalychnis annae),
plasticin-C1 and plasticin-C2 (from Agalychnis callidryas), and plasti-
cin-DA1 (from Pachymedusa dacnicolor), and the cationic plasticin-B1
(from Phyllomedusa bicolor) (Table 3). These 23–29-residue peptides
are rich in glycine and leucine (29 and 25% on average) and contain 1
to 4 repeats of the glycine-zipper motif GXXXG (where X is any
residue). Contrasting with amphipathic helical dermaseptins, plasti-
cins display considerable conformational ﬂexibility and polymorph-
ism that modulates their ability to bind to and disrupt the bilayer
membranes of prokaryotic and eukaryotic cells, and/or to reach
intracellular targets.
5.1. The plasticins: orthologous peptides with different structural and
functional properties
Plasticins have very similar amino acid sequences, but differ
markedly in their net charge and activity spectra. For instance,
plasticin-B1 with a net charge of +2, contains 2 positively chargedTable 5
(A) Antimicrobiala and cytotoxicb activities of plasticins; (B) Membrane-bound conformatio
(A) Microorganisms DRP-PBN2 DRP-PD 3-6
Gram-negative bacteria
Escherichia coli B 6.25 R
Enterobacter cloacae 12.5 R
Klebsiella pneumoniae 6.25 R
Salmonella enteritidis 3.1 R
Clostridium perfringens 50 R
Listeria monocytogenes 25 R
Neisseria meningitidis 50 R
Vibrio Cholerae 25 R
Pseudomonas aeruginosa 3.1 R
Salmonella typhimurium 3.1 R
Gram-positive bacteria
Staphylococcus haemolyticus 50 300
Staphylococcus aureus 6.25 250
Streptococcus pneumoniae 6.25 nd d
Bacillus megaterium 25 R
Burkholderia cepacia R c R
Yeasts
Candida albicans 50 R
Saccharomyces cerevisiae 50 R
% hemolysis at 50 μM 30 42
HeLa cellsh ++ nd
a The antimicrobial activity is expressed as MIC (μM), the minimal peptide concentration
b Evaluated by video microscopy.
c Strains were considered resistant when their growth was not inhibited by peptide conc
d Not determined.
e Adsorption density obtained by surface plasmon resonance.
f PL represents the complex between peptide and membrane corresponding to the penetra
desorption by SPR.
g 1727/1742 ratio increase (%) corresponding to membrane interface (νCO) determined b
h Percentage of νASCH modiﬁcation compared to pure phospholipids established by FTIRlysine residues. These lysine residues are replaced by asparagines and
glycine in plasticin-DA1. An additional aspartate residue in position 5
of plasticin-DA1 generates a peptide with a net charge of 0. The 2
peptides have identical overall hydrophobicities and amphipathicities,
corresponding to a hydrophobic sector that subtends a radial angle of
180° on a helical wheel projection, in contrast to Drs-B2 presenting a
radial angle of 120° (Fig. 3). Positive charge distribution differs for
plasticins and Drs-B2. Drs-B2 appears uniformly positively charged,
while the positives charges of plasticins are presented as N-terminal
lobes. Glycine residues are predominant within the polar surface of
the helix of plasticins, while leucine is predominant on the nonpolar
surface. Despite their orthologous relationships and very similar
sequences, the spectra of action of pasticin-B1 and plasticin-DA1 differ
considerably (Table 5). Cationic plasticin-B1 was bactericidal against
most of the tested microorganisms at μM concentrations and
permeabilized the cytoplasmic membrane of E. coli, but neutral
plasticin-DA1 was virtually inactive and did not permeate the
bacterial membrane. However, both peptides have similar, albeit
moderate hemolytic activities [39].
Incubation of HeLa cells with 100 μM plasticin-B1 induces cell
necrosis after 3 h, whereas after 24 h, this plasticin at a concentration
of 10 μM provokes damage in the plasma membrane and changes in
cell morphology with local membrane fusion, formation of large
polynucleated cells, and alteration of the nuclei, inﬂuencing con-
densation and fragmentation as attested by the presence of apoptotic
bodies.
5.2. Bilayer lipid composition modulates the conformation of membrane-
bound plasticins
Despite very similar amino acid sequences, plasticins adopted
various conformations at anionic and zwitterionic membrane inter-
faces including helices, destabilized helix states, β-hairpin, β-sheet
and disordered states (Table 5). Plasticin-B1 is mainly helical when
bound to anionic DMPG or zwitterionic DMPC phospholipid vesicles,n, membrane adsorption density, membrane perturbation of plasticins
(B) DRP-PBN2 DRP-PD 3–6
DMPG
Membrane-bound conformation
% helix 65 64
% β-structure 0 9
DMPG adsorption density
ng.nm−2 e 2.8 0.1
PL (ng.mm−2) f 1.2 0
Membrane perturbation
Membrane interface (%) g 23 17
Hydrophobic core (%) h 5 4
DMPC
Membrane-bound conformation
% helix 47 16
% β-structure 27 62
DMPC adsorption density
ng.nm−2 e 1.2 0.2
PL (ng.mm−2) f 0.3 0.1
Membrane perturbation
Membrane interface (%) g 13 0
Hydrophobic core (%) h 4 0
required for total inhibition of cell growth in liquid medium.
entrations up to 400 μM.
tion of the peptide into the hydrophobic core of the bilayer as quantiﬁed after 10 min of
y Fourier transform infrared spectroscopies.
spectroscopies.
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zwitterionic vesicles. Plasticin-DA1 adopts a helical structure when
bound to anionic vesicles but is β-sheeted in the presence of
zwitterionic phospholipids. CD spectroscopy and NH/ND-exchange
kinetics obtained by ATR-FTIR showed that plasticin-DA1 self-
associates when bound to DMPG vesicles [39]. Molecular dynamics
simulations performed in apolar medium starting from an ideal helix,
demonstrated that plasticin-DA1 underwent transitions between
three conformations (helix/coil/β-structure), while cationic plasti-
cin-B1 oscillated between helix and disturbed helix. These observa-
tions shed light on the differences in structural malleability of closely
related peptides and revealed the potential foldability within β-
hairpin conformations of plasticins [39,40].
It has often been reported that antimicrobial potency is associated
with an amphipathic structure, being either anα-helix or a β-sheet [41–
43]. While all plasticins displayed a pronounced amphipathic character
whenmodelled as a helix, this propertywas completely disruptedwhen
peptides are represented in β-structures. Disruption of amphipathicity
in β-sheeted conformations (either hairpin shaped or extended)may be
a key for explaining differential potencies. Membrane-bound cationic
plasticin-B1 exhibits antimicrobial activity when displaying anα-helix/
β-structure ratio ≥1. In contrast, neutral plasticin-DA1 has an α-helix/
β-structure ratio b1 when bound to phospholipid membranes, and is
devoid of antimicrobial activity (Table 5).
5.3. The glycine-zipper motif GXXXG and self-association of plasticins
Selectivity and potency of antimicrobial peptides may additionally
depend on properties other than their lipid-binding characteristics.
Peptides need to cross the cell wall before reaching the cytoplasmic
membrane, a process that depends on the structure and oligomeric
state of the peptide. It has also been proposed that some peptides that
disrupt membranes via a carpet mechanism approach the membrane
in an oligomeric state and have a highly helical arrangement before
coming in contact with the membrane [44]. The amino acid sequences
of plasticins resemble those of transmembrane protein segments, and
encompass several GXXXG motifs that are known to mediate
interactions between transmembrane or fusion peptide helices [45].
The impact of GXXXGmotifs on plasticin self-associationwas assessed
by SDS-PAGE and measurement of translational diffusion coefﬁcients
by pulse ﬁeld gradient NMR experiments (unpublished data).
Although these experiments revealed the existence of a monomer–
dimer equilibrium, the GXXXG motifs were not shown to promote
strong oligomerization of plasticins to the same extent as the dimeric
transmembrane segment of glycophorin A [45]. Other factors may be
involved, such as the sequence context or intrinsic conformational
ﬂexibility.
5.4. Antimicrobial activity of cationic plasticins and interaction with
anionic membranes
Cationic plasticin-B1 is mainly helical when bound to anionic
DMPG mimetic membranes but can also adopt alternative conforma-
tions including β-hairpin-like structures at this interface [39,46]
(Table 5). This is in contrast to magainin and cecropin, which also
adopt helical structures at an air–water interface, whereas melittin
only adopts a helical structure in the presence of lipids [47]. Plasticin-
B1 forms peptide multilayers when adsorbed onto DMPG bilayer and
binds to anionic membranes in a two-step process (Table 5). In a ﬁrst
step, the peptide binds to the membrane surface because of the
hydrophobic effect and several non-speciﬁc interactions. In a second
step, the subsequent formation of the peptide helix result in tightly
bound peptide–lipid complexes that are primarily stabilized by the
aliphatic and aromatic residues. Plasticin-B1 interacts with DMPG by
decreasing the associated water content of the phospholipid heads,
replacing water molecules by peptides themselves [39]. This suggeststhat the peptide may act via other ways than the breakdown of
cytoplasmic membrane permeability. The interaction of the peptide
with alkyl chains of DMPG phospholipids results in noticeable
disordering of the acyl chain region of the ﬂuid bilayer, probably
due to gel to liquid–crystalline phase transition, or as a consequence of
peptide insertion [48,49]. The abilities of plasticins to act on lipid
membranes were also related to their potential to cross membranes,
thus targeting the cytoplasm or nucleus. Consequently, plasticin-B1,
giving the highest complex density in a DMPG bilayer (Table 5), is
believed to have the strongest capacity to cross membranes.
5.5. Cytotoxic activity of cationic plasticins and interaction with
zwitterionic membranes
Cationic plasticin B1 is mainly helical when bound to zwitterionic
DMPC phospholipid vesicles, although the β-sheet structure con-
tribution increases (Table 5). In contrast, it forms peptide multilayers
when adsorbed onto the DMPC bilayer and binds to zwitterionic
membranes in a two-step process as for anionic membranes. Never-
theless the peptide–lipid complex density is weaker, indicating a
lower afﬁnity for DMPC bilayers compared to DMPG. Plasticin-B1,
mainly in α-helix conformation, is adsorbed to the same extent as
dermaseptin B2 [50]. FTIR spectroscopy revealed that the binding of
the peptides at the interface of the zwitterionic membrane results in
membrane dehydration, formation of peptide–membrane hydrogen
bonds and alteration of the νAS(CH2–CH3) modes, indicating that the
peptide interacts with the bilayer core (Table 5). Altogether, these
biophysical data demonstrate the ability of cationic plasticin-B1 to
oligomerize in zwitterionic membranes, partially through gain of β-
structures. Beta structure contents could thus be used as an indicator
of cytotoxic potency in the plasticin family.
5.6. Membrane-active neutral plasticins
A few membranotropic frog skin peptides bearing no net charge
have been reported in the literature [51–54]. These peptides were
found to be inactive against bacterial strains in vitro. The lack of
measurable growth-inhibitory activity of neutral peptides toward
bacteria is consistent with the proposal that the positive charge on the
peptide is important for binding to the negatively charged phospho-
lipids of the bacterial cell membrane. Nevertheless, it has been shown
that neutral frog skin peptides can have a potent activity against
microorganisms that the frog may encounter in the wild [55,56]. The
fact that the structure of plasticin-DA1 differs greatly in the presence of
anionic or zwitterionic vesicles demonstrates that this peptide has
versatile conformations at membrane surfaces, i.e., the same amino
acid sequence can have several conformations, depending almost
exclusively on the lipid molecular environment. Thus, an amphipathic
helical structure is not sufﬁcient, in this case, for bacterial membrane
disruption. Neutral plasticin-DA1, which interacts with anionic or
zwitterionic phospholipid vesicles, mainly via hydrophobic interac-
tions [39], is only weakly adsorbed in the micromolar range of
antibacterial activity concentrations (Table 5). The lack of a positivenet
charge did not prevent peptide adsorption, but could prevent further
rearrangements in the bilayer to form stable peptide–lipid complexes
with lifetimes compatible with biological activity. Although plasticin-
DA did not produce bacterial membrane leakage [6], it perturbes the
peptide-DMPG vesicle interface and bilayer alkyl chains at millimolar
concentrations, suggesting insertion into bacterial membranes. Sur-
prisingly, neutral plasticin-DA1 induces no perturbation on DMPC
vesicles, while it presents hemolytic activities in vitro. During bacterial
attack, many peptides can be retrieved in frog skin secretions. The
resulting cocktail contains simultaneously neutral, anionic, and
cationic peptides. Since inactive neutral peptides enhance the activity
of cationic peptides, they may act as primary membrane-disturbing
peptides by adopting a transmembrane orientation.
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conversions and self-association in the presence of anionic membrane
for plasticin-B1. Fluctuations in the antimicrobial potency appear to be
related to shifts within the autoassociation stage altering the
sequentiality of peptide oligomerization. Plasticins illustrate the
various ways a peptide could perturb biomembranes, leading to a
biological activity. As such, plasticins can be used as a general model to
explore the impact of the structural malleability of membrane-active
peptides (antimicrobial, cell-penetrating, and fusion peptides) on
their ability to bind to and disrupt membranes of prokaryotic and
eukaryotic cells, and/or to reach intracellular targets.
6. Dermaseptin S9: an amyloidogenic peptide with antimicrobial
and chemoattractant properties
Dermaseptin S9 (Drs-S9), GLRSKIWLWVLLMIWQESNKFKKM, does
not resemble any of the cationic and amphipathic antimicrobial
peptides identiﬁed to date in having a tripartite structure that includes
a highly hydrophobic core sequence encompassing residues 6–15
ﬂanked at both termini by cationic and polar residues (Fig. 3). This
structure is reminiscent of that of synthetic peptides originally
designed as transmembrane mimetic models and that spontaneously
become inserted into membranes [57,58].
6.1. Amyloid-like properties of Dermaseptin S9
Circular dichroism, FTIR and ATR-FTIR spectroscopies combined
with surface plasmon resonance study show that Drs-S9 is structured
as stable and ordered β-sheet aggregates in aqueous buffers, or once
bound to anionic or zwitterionic phospholipid vesicles. Drs-S9 freshly
dissolved inwater or in PBSmigrated with apparent molecular masses
of 6 kDa and 12 kDa in SDS-PAGE gels suggesting that Drs-S9 could be
self-associated as dimers or tetramers [59–61] (Fig 5). These
structures slowly assembled into amyloid-like ﬁbrils of 8 nm of
diameter in aqueous environments via spherical intermediates that
were visualized after 3 days and 7 days of incubation at 37 °C,
respectively by electron microscopy and Congo red staining (Fig. 5).
Furthermore, the self-associating properties of Drs-S9 were also
corroborated by slow NH/ND-exchange kinetics monitored by ATR-
FTIR [61].
Amyloidogenic peptides self-assemble, probably through speciﬁc
molecular interaction patterns, generating ordered mature ﬁbrils [62].Fig. 4. Schematic view of the impact of preorganized structure of cationic plasticin-B1 and
properties and antimicrobial potency.It is thought that due to the multiple aromatic residues present in
amyloid-like peptides, π–π stacking plays a crucial role in the
ﬁbrillization process, by reducing the energetic barrier [63,64]. Since
Drs-S9 bears a hydrophobic core-sequence (residues 8–15) rich in
aromatic residues, the peptide can potentially establish π–π interac-
tions [65] that could be at the origin of its amyloid-like behavior. The
structural properties of most of the amyloidogenic peptides are
environment-dependent. For example, Aβ1–42 is α-helical in the
presence of TFE [66], while it is poorly structured and aggregated in
water, and β-sheet structured in phosphate buffer solutions. In the
sameway, Drs-S9 adopted a non-amphipathic α-helical conformation
in TFE/water mixtures, but was highly aggregated in aqueous
solutions and in the presence of SDS micelles (Fig. 3) [67].
6.2. Dermaseptin S9 induced chemotaxis via a seven -transmembrane G
protein-coupled cell surface receptor
Drs-S9 triggered the chemotactic migration of human neutrophils,
T lymphocytes and THP-1 monocytes with a maximal response for a
concentration of 50 μM. Drs-S9 chemotactic activity seemed to be only
partially sensitive to pertussis toxin and to ERK1/ERK2-dependent
signaling. The cells' desensitization to Drs-S9 following a pre-
treatment with Aβ1–42 or fMLP suggests that Drs S9 could partially
induce chemotaxis through the seven-transmembrane Gα protein-
coupled FPRL1 receptor [68], and through an additional non-PTX
sensitive receptor. Only few studies dealing with chemoattractive
properties have been reported for frog antimicrobial peptides. They
are all related to amphipathic α-helical peptides, such as Drs-S1 [33]
or temporin A and analogues [69]. Drs-S1 and temporin Awere shown
to be chemotactic at 10 and 250 nM, respectively, contrasting with
Drs-S9 that was found to induce the directional migration of
neutrophils, monocytes and T lymphocytes within the same range of
concentration reported for Aβ1–42 [68]. Moreover, Drs-S9-induced
chemotaxis results from a β-structured peptide, whereas theα-helical
Drs-B2 had a poor chemotactic potential under similar conditions.
6.3. β-amyloid-like behavior of Dermaseptin S9 modulates its
chemotactic and antimicrobial activities
Antimicrobial and chemotactic activities of Drs-S9 are modulated by
its amyloid-like properties. Drs-S9 induced cell migration with a
maximum efﬁciency for freshly dissolved peptide. Drs-S9 dissolved instructural inter-conversions at anionic membrane interface for membrane-disturbing
Fig. 5. Summary of the main oligomerization states adopted by Dermaseptin S9 in relation with its biological activities. At day 0, freshly dissolved Drs-S9 is mainly dimeric or
tetrameric (soluble oligomers) and exhibits maximal chemotactic activity. At day 3, Drs-S9 is associated into cytotoxic spherical oligomers with a potent antimicrobial activity. At day
7, Drs-S9 forms in amyloid-like ﬁbrils.
Table 6
Effect of aging on the antimicrobial activity of dermaseptin S9 and dermaseptin B2
Bacterial strains MIC (μM)
Dermaseptin S9 Dermaseptin B2
Day 0 Day 3 Day 7 0, 3, and 7 days
Citrobacter rodentium 12.5 6.5 50 /
Salmonella typhimurium 25 6.5 100 3.1
Escherichia coli EPEC 50 12.5 100 3.1
Escherichia coli JPN15 50 25 R 0.2
Peptides were freshly dissolved in, or incubated during 3 or 7 days in PBS or H20 at 37 °C
before testing. The antimicrobial activity is expressed as MIC (μM), the minimal peptide
concentration required for total inhibition of cell growth in liquid medium. Strains were
considered resistant (R) when their growth was not inhibited by peptides
concentrations N100 μM.
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bacteria strains tested at day 0. The antibacterial activity of 3 days-
aged Drs-S9 in PBS (Table 6) was stronger than that of Drs-S9 at day 0.
After 7-days of incubation in PBS at 37 °C, the peptide exhibited little or
no antibacterial activity. Moreover, after removing the Drs-S9 from the
wells and replacing it with fresh LB medium overnight, none of the
sensitive strainswas capable of resuminggrowth, suggesting thatDrs-S9
is a bactericidal agent. Altogether, these data point out that Drs-S9 is a
more potent bactericidal agent in its oligomeric spherical form detected
at 3 days of incubation at 37 °Cwhile it is a potent chemoattractant in its
soluble, low-molecular weight self-associated forms in the same range
of concentration as amyloidogenic peptides Aβ1–42 and PrP106–126.
6.4. Mechanisms of antimicrobial activity
The amyloidogenic properties of Drs-S9 inﬂuence its antibacterial
activity suggesting different modes of membrane permeabilization.
Drs-S9 has a high afﬁnity for anionic model membranes that mimic
bacterial membranes [67]. FTIR data underlined that anionic phos-
pholipid vesicles promoted Drs-S9 structural interconversions from a
β-hairpin into a β-sheet structure. As a consequence, the interaction of
the peptide with alkyl chains of DMPG phospholipids resulted in a
noticeable disturbance of the alkyl chain order of the ﬂuid bilayer,
probably as a consequence of Drs-S9 insertion. These data suggest that
oligomeric β-sheet structured Drs-S9 exerted its microbicidal activity
by perturbing both the membrane interface and the hydrophobic core
of the bacterial membrane (Fig. 5).
It has been demonstrated that IAPP and α-synuclein protoﬁbrils
have the ability to permeabilize synthetic vesicles by a pore-like
mechanism [70]. Interactions of amyloid Aβ 25–35 peptide with
phospholipids were also shown to be based on electrostatic interac-
tions. These interactions are thought to favor the aggregation of the
peptides, and the presence of the aggregates may disturb the lipid–
water interface of the membrane [71]. While monomeric or weaklyself-associated amyloidogenic peptide Aβ1–40 binds rapidly but
reversibly to liposomes, its aggregated form binds slowly but
essentially irreversibly following a 2-step model: partial reversible
adsorption of monomeric Aβ 1–40, followed by an acceleration of
peptide aggregation at the membrane interface, leading to some
degree of irreversible adsorption. A similar behavior could be
attributed a posteriori to Drs-S9 on DMPG vesicles, as assessed by
SPR experiments using L1 sensorchip [67]. In contrast, Drs-S9 was
irreversibly adsorbed on hydrophobic HPA support whatever its
aggregation state. This kind of behavior is also opposed to that of
peptides forming supramolecular protein–lipid amyloid-like ﬁbers
upon binding to negatively charged phospholipid-containing mem-
branes [72–74]. On the other hand, Dermaseptins S were shown to be
active against bacteria and to form aggregates at high peptide/lipid
ratios, whereas Dermaseptins B are peculiarly active against fungi by
forming aggregates at low peptide/lipid ratios [75]. This led to the
proposal that the peptide aggregation state in solution could be an
important factor affecting selective membrane disruption and
cytoxicity. In conclusion, the dual abilities of Drs-S9, killing bacterial
1549P. Nicolas, C. El Amri / Biochimica et Biophysica Acta 1788 (2009) 1537–1550pathogens and activating immunological response, could be of great
interest in the design of immunotherapeutic tools.
7. Concluding remarks
Organisms that produce venomous peptides for prey capture,
defense, or competitor deterrence are very diverse, including spiders,
scorpions, amphibians, cone snails and snakes. The pharmacological
inventory encoded in the genomes of these animals is extraordinary
[76]. It has been estimated that cone snails express 50,000 different
neurotoxins based on a species count of 500 and a toxic repertoire of 100
peptides per venom [77,78]. Scorpions have been estimated to encode a
similar diversity of peptide neurotoxins (100,000) based on a pharma-
cological repertoire of 70 peptides per venom and a species count of
1500 [79]. Spiders, with 80,000 estimated species and 50 peptides per
venom lead to a total of 4 million spider-venom polypeptides. As stated
by Olivera [80], gene products that mediate interactions between
organismsare encodedbyexogenes, a termused to rationalize conotoxin
gene hypermutation. Exogene families that are targeted to other
organism in the environment, such as the conopeptide genes, have to
diversify very rapidly because each species has its own ecological niche.
Thus, the evolutionary history of these genes would be expected to be
strikingly different from the rest of the genome.
This suggest that spiders, scorpions, cone snails and hylid frogs,
have independently evolved a similar mechanism to diversify their
repertoire of toxic polypeptides by duplication of ancestral gene(s)
followed by action of a hypervariability-generating mechanism that
increases the rate of mutation of the mature-toxin loci. The pool of
resulting paralogous genes was then subject to adaptive evolution to
select useful variants, enabling these animals to perform a compre-
hensive search of pharmacophore space. [76]. Accordingly, inactive
paralogs, such as plasticin-AD1, may be part of a bank of variants
assembled by random ﬁxation of non-synonymous mutations, which
are available for further diversifying selection when the microbial
environment or the genetic background changes.
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